Aark Pharma

Delhi, India
Distributes generic pharmaceuticals to hospitals, governments, and patients worldwide.

About Aark Pharma

Aark Pharma is a company based in Delhi (India). It operates as a B2B and D2C. Aark Pharma offers products and services including Anticancer Medicines, Antibacterial Medications, Diabetes Medicines, and Cardiovascular Medicines. Aark Pharma operates in a competitive market with competitors including AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.

  • Headquarter Delhi, India
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website aarkpharma.com
  • Social X Facebook
  • Legal Name Aark Pharmaceuticals India Private Limited
  • Date of Incorporation 23 Nov, 2013
  • Jurisdiction New Delhi, Delhi, India
Key Metrics
  • Net Loss
    -₹22,560

    FY 2024 · 0% margin

  • EBITDA
    -₹2,560

    FY 2024 · 0% margin

Products & Services of Aark Pharma

Aark Pharma offers a comprehensive portfolio of products and services, including Anticancer Medicines, Antibacterial Medications, Diabetes Medicines, and Cardiovascular Medicines.

Anticancer Medicines
Oncology Drugs

Treatments for cancers like breast and lung tumors

Antibacterial Medications
Infectious Disease Drugs

Medications to combat bacterial infections

Diabetes Medicines
Endocrinology Drugs

Drugs for managing blood sugar levels

Cardiovascular Medicines
Heart Health Drugs

Treatments for heart conditions and blood pressure

Board of directors of Aark Pharmaceuticals India Private Limited (Aark Pharma)

Aark Pharmaceuticals India Private Limited is the primary company behind Aark Pharma. The board of Aark Pharmaceuticals India Private Limited currently have 2 directors; the longest-serving is Sanjeev Kansal, appointed in 2013. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Sanjeev Kansal
DIN 01698307
Director23 Nov 201312 yrs 10 moAark Pharmaceuticals India Private Limited
Geetika Kansal
DIN 06658535
Director23 Nov 201312 yrs 10 moAark Pharmaceuticals India Private Limited

Financials of Aark Pharma

Figures of Aark Pharmaceuticals India Private Limited, the primary company behind Aark Pharma, for FY 2024. Net loss was -₹22,560 (0% margin). EBITDA was -₹2,560 (0% margin).

  • -₹22,560Net loss · 0% margin
  • -₹2,560EBITDA · 0% margin
  • ₹7.5 LakhPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Aark Pharmaceuticals India Private Limited are on its company page.

Premium access

Detailed financial statements for Aark Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Aark Pharma

Aark Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
amerisourcebergen.com1985Chesterbrook, United States–46,000
Pharmaceutical distribution and supply chain services are provided globally.
enterohealthcare.com2018Mumbai, India$59.67M817
India's leading healthcare products distribution platform
keimed.com2000Hyderabad, India$16.62M588
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed.
sandor.co.in1995Hyderabad, India$11.53M161
Provider of medical equipment, devices, and drugs distribution services
mahaveermedi.com2016Bengaluru, India–588
Serves as a distributor of a wide range of pharmaceutical drugs.
dipnapharmachem.com2011Ahmedabad, India––
Distributor of pharmaceutical raw materials
Premium access

Detailed competitors of Aark Pharma

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Aark Pharma

The website of Aark Pharma (aarkpharma.com) receives about 4.8K visits a month.

  • Monthly visits
    4.8K

    ▼ 16.6% vs previous month

Similar websites

Websites whose visitors overlap most with Aark Pharma. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
southdelhipharma.com
100%
–#9,285,864View details
salvepharma.com
94%
33.4K#772,079View details

Similar companies to Aark Pharma

10 companies that operate in the same segment as Aark Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 215.5 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Aark Pharma

Aark Pharma is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

Aark Pharmaceuticals specializes in the distribution and export of generic medicines across multiple therapeutic areas, including anticancer, diabetes, and antibacterial drugs. They supply to government hospitals, corporate hospitals, and direct-to-patient services, operating from New Delhi, India. The company partners with major pharmaceutical firms and serves clients like railway hospitals and private healthcare providers, focusing on life-saving drugs and specialized solutions.

Aark Pharma's top competitors include Entero Healthcare, AmerisourceBergen and Keimed.

Aark Pharma offers Anticancer Medicines, Antibacterial Medications, Diabetes Medicines, and Cardiovascular Medicines.

Aark Pharma operates through Aark Pharmaceuticals India Private Limited.

The legal entities of Aark Pharma currently have 2 directors, including Sanjeev Kansal, Geetika Kansal.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available